Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome

Completed · Phase 2/Phase 3

Conditions studied: Fibromyalgia

In brief

The primary objective is to evaluate the long-term safety of desvenlafaxine succinate sustained-release (DVS SR) during open-label treatment in adult outpatients with fibromyalgia syndrome.

Key facts

Study ID

NCT00424892

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

600

Expected to finish

2007-06-01

Last updated by the study team

2007-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Outpatients who have completed double-blind treatment in study 3151A4-327 for fibromyalgia Syndrome with no major protocol violations and no events that would preclude the patient's entry into the long-term open-label study.
• Women of childbearing potential must have a negative serum pregnancy test result at study start.

You may not qualify if…

• Presence of any new/and or clinically important medical condition that might compromise patient's safety.
• Use of prohibited treatment.
• Meets any of the exclusion criteria listed for study 3151A4-327.

Where it is running

• Study site — Mobile, Alabama, United States
• Study site — Phoenix, Arizona, United States
• Study site — Anaheim, California, United States
• Study site — Sacramento, California, United States
• Study site — San Diego, California, United States
• Study site — Santa Ana, California, United States
• Study site — Walnut Creek, California, United States
• Study site — Denver, Colorado, United States
• Study site — Cromwell, Connecticut, United States
• Study site — Brooksville, Florida, United States
• Study site — DeLand, Florida, United States
• Study site — Delray Beach, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Palm Beach Gardens, Florida, United States
• Study site — Pembroke Pines, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — Sunrise, Florida, United States
• Study site — Tamarac, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Decatur, Georgia, United States
• Study site — Smyrna, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.